精品国产一区二区桃色

Member News

FASEB names advocacy fellows

ASBMB Today Staff
Dec. 18, 2023
Kaitlyn Browning
Natalie Gehred
Katy Lehmann

The Federation of American Societies for Experimental Biology recently named its inaugural . Three 精品国产一区二区桃色 members were among the first nine fellows: Kaitlyn Browning, Natalie Gehred and Katherine Lehmann. FASEB created this fellowship to help trainees develop their skills as science advocates.

is a graduate student in the lab of , a professor of biochemistry at Vanderbilt University. Her research is focused on understanding bacterial evolution and multidrug-resistant bacterial infections. Browning participated in a federal science policy workshop through Vanderbilt during which she traveled to Washington, D.C. She also completed a science communication internship with the Vanderbilt Institute for Infection, Immunity and Inflammation. Browning looks forward to learning about science policy careers as well as how to make herself a competitive candidate for these roles during the fellowship.

is a graduate student at UCLA, conducting research in the lab of , a professor of anesthesiology, medicine and physiology. Gehred’s work uses molecular transcriptomics to examine the mechanisms that underlie cardiac fibrosis. At UCLA, she is the Science Communication Committee chair of the university’s Science Policy Group, a group of graduate students dedicated to exploring science advocacy. Gehred hopes to use the skills she gains through the fellowship to write an op-ed and lead a writing workshop with the UCLA Science Policy Group.

is a postdoctoral fellow at Oregon Health & Science University. She conducts research in the lab of , a senior scientist and director of the Vollum Institute at OHSU. Lehmann’s work aims to understand the neuron and glial cell signaling mechanisms involved in synaptic pruning. She participated in the Training Future Faculty program at OHSU and served as a visiting professor at Lewis & Clark College, a local liberal arts school. There, she implemented a curriculum incorporating equity practices in an introductory science class. During her fellowship, Lehmann aims to advocate for graduate student and postdoc benefits such as increased pay and childcare.

During their 10-month program, the fellows will receive instruction in advocacy, science policy, science communication, leadership development and career exploration outside academia.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Get the latest from ASBMB Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

In memoriam: Ralph G. Yount
In Memoriam

In memoriam: Ralph G. Yount

July 28, 2025

He was a professor emeritus of chemistry and biochemistry at Washington State University and an ASBMB member for 58 years.

From dust to discovery
Profile

From dust to discovery

July 23, 2025

From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women鈥檚 health.

Fliesler wins scientific and ethical awards
Member News

Fliesler wins scientific and ethical awards

July 21, 2025

He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Feature

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

ASBMB members recognized as Allen investigators
Member News

ASBMB members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.